EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development

Paridhi Gupta iD, Zheyi Hu iD, Li Zhu iD, Lora Hamuro iD

Clinical and Translational Science · 2026-11 · 19 (11)

DOI: 10.1111/cts.70769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 01.11.2026. Verfasst von Paridhi Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology, Bristol Myers Squibb, Princeton, New Jersey, USA. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

clinical pharmacology studiesdrug developmenthealthy participantsoncologypatientspharmacokinetics

Autor:innen und Institutionen

  • Clinical Pharmacology, Bristol Myers Squibb, Princeton, New Jersey, USA.

ORCID-Profile: Paridhi Gupta, Zheyi Hu, Li Zhu, Lora Hamuro

Zitieren

APA

Gupta, P., Hu, Z., Zhu, L., & Hamuro, L. (2026). Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development. Clinical and Translational Science, 19(11). https://doi.org/10.1111/cts.70769

Vancouver

Gupta P, Hu Z, Zhu L, Hamuro L. Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development. Clinical and Translational Science. 2026;19(11). doi:10.1111/cts.70769

BibTeX
@article{Gupta2026,
  author = {Gupta, Paridhi and Hu, Zheyi and Zhu, Li and Hamuro, Lora},
  title = {Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {11},
  doi = {10.1111/cts.70769}
}
Kostenlos starten →